Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - A prospective study

Transplant International

Volumn 22, Issue 4, 2009, Pages 455-462

  Park, Jae Berm ^b   Kim, Doo Jin ^a,b,c   Woo, Sook Young ^d   Choi, Gyu Seong ^b   Chun, Jae Min ^b   Jung, Gum O ^b   Kwon, Choon Hyuck D ^b   Kim, Sung Joo ^b   Joh, Jae Won ^b   Lee, Suk Koo ^b  

^a Sungkyunkwan University School of Medicine ^*  (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

Anemia; Kidney transplantation; Parvovirus B19; Viral load

Indexed keywords

CIPOL N; CYCLOSPORIN; CYCLOSPORIN A; GLOBULIN S; HEMOGLOBIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARVOVIRUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; VIREMIA; VIRUS LOAD;

ADULT; ANEMIA; COMORBIDITY; DNA, VIRAL; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; KOREA; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 61849090216     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00818.x     Document Type: Article

References (26)

1. Neild G, Anderson M, Hawes S, Colvin BT. Parvovirus infection after renal transplant. Lancet 1986 2 : 1226.
2. Bertoni E, Rosati A, Zanazzi M, et al. Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients. Transplant Proc 1997 29 : 818.
3. Zolnourian ZR, Curran MD, Rima BK, Coyle PV, O'Neill HJ, Middleton D. Parvovirus B19 in kidney transplant patients. Transplantation 2000 69 : 2198.
4. Ki CS, Kim IS, Kim JW, et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant 2005 19 : 751.
5. Cavallo R, Merlino C, Re D, et al. B19 virus infection in renal transplant recipients. J Clin Virol 2003 26 : 361.
6. Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J. A Cluster of Parvovirus B19 Infections in Renal Transplant Recipients: A Prospective Case Series and Review of the Literature. Am J Transplant 2006 6 : 225.
7. Marchand S, Tchernia G, Hiesse C, et al. Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 1999 13 : 17.
8. Wong T, Chan P, Leung C, Szeto C-C, Tam J, Li P. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999 34 : 1132.
9. Pamidi S, Friedman K, Kampalath B, Eshoa C, Hariharan S. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients. Transplantation 2000 69 : 2666.
10. Garewal G, Ahluwalia J, Varma N, Das R, Sakhuja VK. Parvovirus B19 infection-associated red-cell aplasia in renal-transplant recipients: clues from the bone marrow. Transplantation 2004 77 : 320.
11. Renoult E, Bachelet C, Krier-Coudert MJ, Diarrassouba A, Andre JL, Kessler M. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection. Transplant Proc 2006 38 : 2321.
12. Moudgil A, Shidban H, Nast CC, et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997 64 : 1847.
13. Lauchenbruch PA. Analysis of data with clumping at zero. Biom Z 1976 18 : 351.
14. Lachenbruch PA. Comparisons of two-part models with competitors. Stat Med 2001 20 : 1215.
15. Miller R, Seigmund D. Maximally select chi square statistics. Biometrics 1982 38 : 1011.
16. Murer L, Zacchello G, Bianchi D, et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000 11 : 1132.
17. Vanrenterghem Y. Anaemia after renal transplantation. Nephrol Dial Transplant 2004 5 : V54.
18. Braham S, Gandhi J, Beard S, Cohen B. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections. J Clin Virol 2004 31 : 5.
19. Bertoni E, Rosati A, Zanazzi M, et al. Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. J Nephrol 1997 10 : 152.
20. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000 14 : 586.
21. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Toda F, Toma H. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. Transplant Proc 2000 32 : 1967.
22. Liefeldt L, Buhl M, Schweickert B, et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 2002 17 : 1840.
23. Brown KE. Detection and quantitation of parvovirus B19. J Clin Virol 2004 31 : 1.
24. Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994 330 : 1192.
25. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995 172 : 1198.
26. Wierenga KJ, Pattison JR, Brink N, et al. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet 1995 346 : 475.